Celldex Therapeutics reported $-80.62M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
AbbVie USD 6.88B 156M Sep/2026
Agenus USD 15.05M 656K Mar/2026
Amgen USD 4.68B 65M Sep/2026
Bristol-Myers Squibb USD 255M 44M Sep/2026
Celldex Therapeutics USD -80.62M 3.81M Jun/2026
Glaxosmithkline GBP 2.15B 157M Sep/2026
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Northwest Biotherapeutics USD -10.9M 3.42M Mar/2026
Pfizer USD 4.85B 5.03B Sep/2026
Rigel Pharmaceuticals USD 447K 1.52M Jun/2024
Roche Holding CHF 11.46B 1.91B Jun/2026